Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
- Status
- COMPLETED
- Phase
- NA
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
- Status
- UNKNOWN
- Phase
- PHASE2
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide In Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
- Status
- COMPLETED
- Phase
- PHASE2
Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue
- Status
- COMPLETED
- Phase
- PHASE2